Merck
CN
所有图片(2)

文件

OP92

Sigma-Aldrich

抗-BRCA1(Ab-1)小鼠mAb(MS110)

liquid, clone MS110, Calbiochem®

登录查看公司和协议定价

别名:
抗乳腺癌易感蛋白

生物来源

mouse

质量水平

抗体形式

purified antibody

antibody product type

primary antibodies

克隆

MS110, monoclonal

形式

liquid

包含

≤0.1% sodium azide as preservative

species reactivity

human

manufacturer/tradename

Calbiochem®

储存条件

do not freeze

同位素/亚型

IgG1

运输

wet ice

储存温度

2-8°C

target post-translational modification

unmodified

Gene Information

human ... BRCA1(672)

一般描述

可识别MCF-7细胞中的~220 kDa BRCA1蛋白。不与血型抗原或生长因子受体(如EGFR)发生交叉反应。根据美国专利号5,753,441和6,162,897的许可证销售。
抗BRCA1(Ab-1),小鼠单克隆,克隆MS110,可识别MCF-7细胞中的~220 kDa BRCA1蛋白。它经过验证可用于冷冻和石蜡切片的WB、IF、IP分析。
通过用指定的免疫原免疫小鼠并将脾细胞与NS1小鼠骨髓瘤细胞融合而产生的纯化小鼠单克隆抗体。可识别~220 kDa BRCA1蛋白。

免疫原

表位:BRCA1的N末端304个氨基酸内
重组人BRCA1

应用

冰冻切片(见应用参考文献)

免疫印迹(2 µg/ml)

免疫荧光(见应用参考文献)

免疫沉淀(见应用参考文献)

石蜡切片(见应用参考文献)

包装

请参考特定浓度批号的标签。

警告

毒性:标准处理(A)

外形

溶于50 mM磷酸钠缓冲液(pH 7.5),含0.2%明胶。

分析说明

阳性对照
MCF7细胞

其他说明

Scully, R., et al. 1996.Science272, 123.
Gudas, J.M., et al. 1996.Cell Growth Differ.7, 717.
Vaughn, J.P., et al. 1996.Cell Growth Differ.7, 711.
Goldgar, D.E. and Reilly, P.R.1995.Nat. Genet.11, 113.
Merajver, S.D., et al. 1995.Clin. Can.Res.1, 539.
Merajver, S.D., et al. 1995.Nat. Genet.9, 439.
Struewing, J.P., et al. 1995.Nat. Genet.11, 198.
Thompson, M.E., et al. 1995.Nat. Genet.9, 444.
Futreal, P.A., et al. 1994.Science266, 120.
Miki, Y., et al. 1994.Science266, 66.
Wilson, C.A., et al. 1999.Nat. Genet.21, 236.
在单个系统中,应对抗体进行滴定以获得最佳结果。

法律信息

根据美国专利号5,753,441和6,162,897的许可证销售。
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

12 - Non Combustible Liquids

WGK

nwg

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

为方便起见,与您过往购买产品相关的文件已保存在文档库中。

访问文档库

难以找到您所需的产品或批次号码?

在网站页面上,产品编号会附带包装尺寸/数量一起显示(例如:T1503-25G)。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题?欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ (Lot或Batch)字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等,请输入去除前两位字母的批号:09019TO。

  • 如果您查询到的批号含有填充代码(例如05427ES-021),请输入去除填充代码-021的批号:05427ES。

  • 如果您查询到的批号含有填充代码(例如 STBB0728K9),请输入去除填充代码K9的批号:STBB0728。

未找到您寻找的产品?

部分情况下,可能未在线提供COA。如果搜索不到COA,可在线索取。

索取COA

J Xu et al.
International journal of oncology, 34(4), 939-949 (2009-03-17)
BRCA1 dysfunction is associated with hormone-responsive cancers. We have identified a consensus SUMO modification site in the amino-terminal region of BRCA1/1a/1b proteins and the mutation in this potential SUMO acceptor site (K 109 to R) impaired their ability to bind
Pierre Thouvenot et al.
Journal of cell science, 129(23), 4366-4378 (2016-11-02)
Understanding the effect of an ever-growing number of human variants detected by genome sequencing is a medical challenge. The yeast Saccharomyces cerevisiae model has held attention for its capacity to monitor the functional impact of missense mutations found in human
Geon Kim et al.
Oncology letters, 17(6), 5023-5029 (2019-06-13)
Breast cancer type 1 susceptibility protein (BRCA1) is a tumor suppressor gene that encodes a nuclear phosphoprotein, which is involved in homologous recombination to repair DNA double strand breaks and maintain genome stability. When BRCA1 is mutated or altered, DNA
Hong Wang et al.
Cancer research, 70(15), 6258-6267 (2010-07-16)
The tumor suppressor BRCA1 is a nuclear shuttling protein. However, the role of BRCA1 localization in the control of its functions remains to be elucidated. Given the central role of BRCA1 in DNA damage repair, we hypothesized that depletion of
Nathalie van den Tempel et al.
Cancers, 11(1) (2019-01-18)
The DNA damage response (DDR) is a designation for a number of pathways that protects our DNA from various damaging agents. In normal cells, the DDR is extremely important for maintaining genome integrity, but in cancer cells these mechanisms counteract

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门